Venlafaxine (US brand name Effexor XR® and generic) was the first serotonin-norepinephrine reuptake inhibitor to be approved for use in the US, in 1994. Here is basic information about this medication.
FDA-approved indications
1. Major Depressive Disorder (MDD)
2. Generalized Anxiety Disorder (GAD)
3. Social Anxiety Disorder (SAD)
4. Panic Disorder (PD)
Dosage
Major depressive disorder
Starting dose: 37.5 –75 mg/day
Target dose: 75 mg/day
Maximum dose: 225 mg/day
Generalized anxiety disorder
Starting dose: 37.5 to 75 mg/day
Target dose: 75 mg/day
Maximum dose: 225 mg/day
Social anxiety disorder
Starting dose: 75 mg/day
Target dose: 75 mg/day
Maximum dose: 75 mg/day
Panic Disorder
Starting dose: 37.5/day
Target dose: 75 mg/day
Maximum dose: 225 mg/day
Dosage forms and strengths (USA)
Extended-release capsules (Effexor XR® and generic): 37.5 mg, 75 mg and 150 mg
Extended-release tablets (generic): 37.5 mg, 75 mg, 150 mg, and 225 mg
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Related Pages
Combining antidepressants: Venlafaxine and bupropion
Venlafaxine (Effexor XR®) vs an SSRI
Combining antidepressants: Are two better than one?
Antidepressants: Index and Links
Psychopharmacology: Index and Links
References
Prescribing information for venlafaxine extended-release (Effexor XR®)
Copyright 2015, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply